TEVA PHARMS USA FDA Approval ANDA 213162

ANDA 213162

TEVA PHARMS USA

FDA Drug Application

Application #213162

Application Sponsors

ANDA 213162TEVA PHARMS USA

Marketing Status

None (Tentative Approval)001
None (Tentative Approval)002
None (Tentative Approval)003

Application Products

001CAPSULE;ORAL100MG0DROXIDOPADROXIDOPA
002CAPSULE;ORAL200MG0DROXIDOPADROXIDOPA
003CAPSULE;ORAL300MG0DROXIDOPADROXIDOPA

FDA Submissions

UNKNOWN; ORIG1TA2020-09-01STANDARD

Submissions Property Types

ORIG1Null31

TE Codes

001PrescriptionAB
002PrescriptionAB
003PrescriptionAB

CDER Filings

TEVA PHARMS USA
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 213162
            [companyName] => TEVA PHARMS USA
            [docInserts] => ["",""]
            [products] => [{"drugName":"DROXIDOPA","activeIngredients":"DROXIDOPA","strength":"UNKNOWN","dosageForm":"UNKNOWN","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"09\/01\/2020","submission":"ORIG-1","actionType":"Tentative Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2020-09-01
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.